$CLNN
Clene Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.15
▲+7.51%+$0.290
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateClene Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CLNN up today? It is at $4.15 (+7.51%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLNN spikes, and full due diligence on CLNN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CLNN 10 times in the last 30 days. Create a free account to track $CLNN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CLNN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on CLNN today, peaking at 6.9x its normal volume. Fresh from the SEC: Clene Inc.: Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystInvestment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders, from the latest SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -73K 0.6% of company | sold 41% | 103K | $454K at $6.20 | May 12, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -22K 0.2% of company | sold 11% | 177K | $150K at $6.75 | May 11, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -73K 0.6% of company | sold 27% | 199K | $496K at $6.80 | May 4, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.05% of company | sold 2.1% | 272K | $35K at $6.01 | May 1, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.04% of company | sold 2.0% | 278K | $35K at $6.08 | Apr 30, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -12K 0.09% of company | sold 4.1% | 283K | $69K at $5.63 | Apr 29, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -2K 0.01% of company | sold 0.5% | 295K | $9K at $5.90 | Apr 28, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.5% of company | sold 17% | 297K | $377K at $6.14 | Apr 21, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -4K 0.03% of company | sold 1.2% | 358K | $26K at $6.12 | Apr 20, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -25K 0.2% of company | sold 6.5% | 363K | $161K at $6.43 | Apr 17, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -8K 0.06% of company | sold 2.0% | 388K | $50K at $6.40 | Apr 16, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.05% of company | sold 1.6% | 396K | $41K at $6.48 | Apr 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
CLNN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on CLNN today, peaking at 6.9x its normal volume. Fresh from the SEC: Clene Inc.: Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders. A material company disclosure like this is often the real catalyst behind a move of this size.
CLNN last traded at $4.15, up 7.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CLNN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLNN 10 times in the last 30 days.
CLNN (Clene Inc. Common Stock) trades on XNAS, with a market cap of about $50M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLNN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLNN discussion
Sign in to ask a question or join the discussion.